IL33 and cancer: To understand the molecular level of the crosstalk between the cancers and CAFs involving IL-33, we confirmed the autocrine and paracrine effects of IL-33 on the expression of CSC properties (Figure 3a–c), including chemoresistance, radioresistance, alterations in drug resistance genes, and antiapoptosis (Figure 3d,e).